Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Gutmann, Hanna
DOB: 18-FEB-1969 (Age: 57)
Gender: female
Address:
Matheo-Roth-Platz 967
4070 Eferding (Austria)
ID: 1078-407870-0 (ECI)
Report
Date: 17-JUL-2018
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Dr. Hohl
Georgestraße 27
4222 Langenstein (Austria)
Specimen
Collected: 17-JUL-2018

Chemistry

Test 17-JUL-2018 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 298.9 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 105.8 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 251.5 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 26.2 L 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows marked dyslipidemia with significantly elevated total cholesterol and LDL, and low HDL levels. This lipid profile is associated with increased cardiovascular risk. Clinical correlation and consideration of lifestyle modification and/or lipid-lowering therapy are recommended. Regular monitoring is advised.